Valneva SE (VALN) - Wutah bathi ing taun lumaku

Simbol resmi perusahaan Valneva SE (VALN)

The YoY earnings per share dynamics demonstrate cash flow volatility, where the value of 34.80 determines the parameter status. The financial stability of Valneva SE (VALN) depends on government contracts and regulatory timelines. Risks are linked to the trials of the Lyme disease vaccine and production disruptions. Growth prospects are based on expanding demand in the tourism sector and the treatment of rare infections.

VALN Wutah bathi resik saben saham ing taun iki Valneva Corp (04.07.2022 - 11.11.2026)

Rincian analitis lan laporan data perusahaan Valneva SE (VALN)

- rega saham lan target rega konsensus:
Bagan owah-owahan rega Valneva Corp|VALN - Target konsensus
- indikator kapitalisasi pasar:
Kapitalisasi pasar Valneva Vaccines|VALN - Nilai Total Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Saham Valneva|VALN - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku valneva.com|VALN - Total Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Valneva SE|VALN - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas valneva.com|VALN - Utang perusahaan|Rasio utang marang nilai buku Valneva Vaccines|VALN - Utang jangka dawa perusahaan|Utang jangka cendhak Valneva|Likuiditas cepet valneva.com
- data bathi lan kelipatan valuasi:
VALN - Bathi resik|Proyeksi bathi mangsa ngarep Valneva SE|VALN - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Valneva Vaccines|VALN - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Valneva Vaccines|VALN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Valneva|VALN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan valneva.com|VALN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Valneva SE
Analisis dhasar perusahaan:Valneva Corp
Produk asil prodhuksi valneva.com

This indicator measures the annual growth of net earnings per share, allowing investors to assess capital generation efficiency and business scaling rates. When analyzing the distribution of annual changes in earnings per share, one should look for sustainable growth, which for Valneva SE (VALN) is supported by long-term government defense contracts and stable demand for specialized vaccines within patent cycles.

Pesaing langsung

Gilead - Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki CDTX|Wutah bathi ing taun lumaku Novavax Pharma|Wutah bathi saben saham ing taun lumaku CureVac N.V. (CVAC)|Prakiraan wutah bathi resik saben saham ing taun iki vir.bio|SIGA Technologies - Wutah bathi resik saben saham ing taun iki|Emergent BioSolutions Inc - Wutah bathi saben saham ing taun lumaku|Atea Pharmaceuticals Inc - Wutah bathi ing taun lumaku|IVVD - Wutah bathi ing taun lumaku|Enanta Pharmaceuticals (ENTA) - Wutah bathi saben saham ing taun lumaku|INO (inovio.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku HilleVax|Wutah bathi saben saham ing taun iki KLRS (Kalaris Therapeutics Inc.)|Wutah bathi ing taun lumaku DYAI|NNVC - Kacepetan wutah bathi saben saham ing taun lumaku|Talphera, Inc. - Wutah bathi resik saben saham ing taun iki|cocrystalpharma.com - Wutah bathi saben saham ing taun lumaku|Traws Therapeutics - Wutah bathi ing taun lumaku|DWTX - Wutah bathi ing taun lumaku|QLGN (Qualigen) - Wutah bathi resik saben saham ing taun iki|AlloVir - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku VBI Vaccines, Inc.|Virios (VIRI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku VXRT